Andrew Cittadine, Chief Operating Officer at Monopar Therapeutics (MNPR), bought 24,000 shares at $0.76 ($18K) on 2024-06-03, disclosed to the SEC on 2024-06-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.76 | 12,000 | $9K | 49.4% |
| 2 | $0.78 | 12,000 | $9K | 50.6% |
| Total | $0.77 avg | 24,000 | $18K | 100% |
| Filing → |
| MNPR | BUY | 2024-05-31 | $23K | — | Filing → |
| MNPR | BUY | 2022-11-16 | $50K | — | Filing → |